Healium develops an AI-assisted handheld 3D ultrasound device for renal sonography, enabling point-of-care diagnosis of chronic kidney disease. This technology provides real-time guidance to clinicians, facilitating early detection and improving access to diagnostic imaging in various healthcare settings.
Funding
Funding not disclosed
Founders
Product
Problem
Chronic Kidney Disease (CKD) often goes undiagnosed until late stages, affecting 850 million people worldwide. Traditional renal sonography requires specialized training, limiting its availability and hindering early detection efforts. This leads to delayed treatment and increased preventable deaths.
Solution
Healium offers an AI-assisted, handheld 3D ultrasound device designed for point-of-care renal sonography, enabling earlier and more accurate diagnosis of CKD. The device provides real-time, on-screen guidance, addressing user-skill barriers and making the technology accessible to medical professionals regardless of their sonography training. By automating 3D ultrasound techniques and incorporating machine learning with hemodynamic modeling, Healium facilitates timely clinical decisions in various healthcare settings, from doctor's offices to remote communities. This technology aims to improve patient outcomes through early detection and intervention.
Target Audience
The primary target audience includes medical professionals in diverse healthcare settings, such as doctor's offices, community hospitals, ambulances, and remote communities, who need accessible and accurate tools for early CKD detection.
Features
- AI-assisted guidance system for real-time, on-screen instructions during renal sonography
- Handheld 3D ultrasound device for point-of-care diagnostics
- Automated 3D ultrasound techniques combined with machine learning
- Hemodynamic modeling for enhanced diagnostic accuracy
- Early detection capabilities for CKD, starting from stage 1
- Advanced usability features to simplify renal imaging for healthcare professionals